Use of nicotine replacement therapy and the risk of acute myocardial infarction, stroke, and death
Open Access
- 30 November 2005
- journal article
- research article
- Published by BMJ in Tobacco Control
- Vol. 14 (6) , 416-421
Abstract
Objective:To determine whether nicotine replacement therapy (NRT) is associated with an increased risk of acute myocardial infarction, acute stroke, or death.Design:Self control case series analysis of data from The Health Improvement Network (THIN) to estimate the relative incidence of myocardial infarction and stroke in four 14 day periods before and after the first prescription for NRT.Setting:THIN is a computerised general practice database.Subjects:Patients contributing data to THIN.Interventions:Observational study of NRT.Main outcomes:Acute myocardial infarction, acute stroke, and death.Results:33 247 individuals had been prescribed NRT, of whom 861 had had a myocardial infarction and 506 a stroke. There was a progressive increase in the incidence of first myocardial infarction in the 56 days leading up to the first NRT prescription (overall incidence ratio 5.55, 95% confidence interval (CI) 4.42 to 6.98), but the incidence fell after this time and was not increased in the 56 days after starting NRT (incidence ratio 1.27, 95% CI 0.82 to 1.97). The results were similar for second myocardial infarction and stroke, and for subgroups of people with pre-existing angina and hypertension. There were 960 deaths in our cohort during a mean follow up period of 2.6 years after starting NRT, with no evidence of an increased mortality in the 56 days after the NRT prescription (incidence ratio 0.86, 95% CI 0.60 to 1.23).Conclusions:The use of NRT is not associated with any increase in the risk of myocardial infarction, stroke, or death.Keywords
This publication has 25 references indexed in Scilit:
- General practitioners with special interests (GPSIs)BMJ, 2002
- WHO Europe evidence based recommendations on the treatment of tobacco dependenceTobacco Control, 2002
- Reducing antibiotic use for acute bronchitis in primary care: blinded, randomised controlled trial of patient information leaflet * Commentary: More self reliance in patients and fewer antibiotics: still room for improvementBMJ, 2002
- Smoking cessation guidelines for health professionals: an updateThorax, 2000
- A Clinical Practice Guideline for Treating Tobacco Use and Dependence: A US Public Health Service ReportJAMA, 2000
- Prescription of transdermal nicotine patches for smoking cessation in general practice: evaluation of cost-effectivenessThe Lancet, 1999
- Smoking Cessation Guidelines for Health Professionals---A guide to effective smoking cessation interventions for the health care systemThorax, 1998
- Cardiovascular Toxicity of Nicotine: Implications for Nicotine Replacement Therapy 11All editorial decisions for this article, including selection of referees, were made by a Guest Editor. This policy applies to all articles with authors from the University of California San Francisco.JACC, 1997
- Five‐Hundred Life‐Saving Interventions and Their Cost‐EffectivenessRisk Analysis, 1995
- Myocardial infarction and nicotine patch: a contributing or causative factor?European Heart Journal, 1993